Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis - Wikidata - wikimedia - TriplyDB

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

http://www.wikidata.org/entity/Q24563038

about

The laboratory diagnosis of Trichomonas vaginalis NMR structural analysis of DNA recognition by a novel Myb1 DNA-binding domain in the protozoan parasite Trichomonas vaginalis Structure of the Trichomonas vaginalis Myb3 DNA-binding domain bound to a promoter sequence reveals a unique C-terminal -hairpin conformation Virtual screening, identification and in vitro testing of novel inhibitors of O-acetyl-L-serine sulfhydrylase of Entamoeba histolytica Natural products in modern life science.Trichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide?Trichomonas vaginalis adherence mediates differential gene expression in human vaginal epithelial cells.Potentiating Metronidazole Scaffold against Resistant Trichomonas: Design, Synthesis, Biology and 3D-QSAR Analysis.Trichomoniasis: evaluation to execution Multifarious transcriptional regulation of adhesion protein gene ap65-1 by a novel Myb1 protein in the protozoan parasite Trichomonas vaginalis.Comparative transcriptomics reveals striking similarities between the bovine and feline isolates of Tritrichomonas foetus: consequences for in silico drug-target identification.Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.Effect of recombinant prophenin 2 on the integrity and viability of Trichomonas vaginalis Novel trichomonacidal spermicides.Characterizing ncRNAs in Human Pathogenic Protists Using High-Throughput Sequencing Technology.Study on ITS1 Gene of Iranian Trichomonas vaginalis by Molecular Methods In vitro trichomonacidal activity and preliminary in silico chemometric studies of 5-nitroindazolin-3-one and 3-alkoxy-5-nitroindazole derivatives.In vitro anti-Trichomonas vaginalis activity of Pistacia lentiscus mastic and Ocimum basilicum essential oil.Trypanocidal, trichomonacidal and cytotoxic components of cultivated Artemisia absinthium Linnaeus (Asteraceae) essential oil.Prevalence of Trichomonas vaginalis Infection in Hamadan City, Western Iran.In Vitro Susceptibility of Iranian Isolates of Trichomonas vaginalis to Metronidazole Hydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against Trichomonas vaginalis.Epidemiology and treatment of trichomoniasis.Recombinant α-actinin subunit antigens of Trichomonas vaginalis as potential vaccine candidates in protecting against trichomoniasis.Transcriptomics Indicates Active and Passive Metronidazole Resistance Mechanisms in Three Seminal Giardia Lines.Epigenome mapping highlights chromatin-mediated gene regulation in the protozoan parasite Trichomonas vaginalis.Strategies for Prevention and Treatment of Trichomonas vaginalis Infections.Proton pump inhibitors are associated with a reduced likelihood for sexually transmitted diseases in women in the emergency department.Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.Trichomonas vaginalis: an audit of clinical practice and the demography of infected patients at three London genitourinary medicine clinics.Clotrimazole as a pharmaceutical: past, present and future.Trichomonas vaginalis: Clinical relevance, pathogenicity and diagnosis.Electrochemical Determination of Metronidazole in Tablet Samples Using Carbon Paste Electrode.Trichomoniasis in older individuals: a preliminary report from Iran.A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.Eicosapentaenoic Acid Modulates Trichomonas vaginalis Activity.Antimicrobial activity of organometallic isonicotinyl and pyrazinyl ferrocenyl-derived complexes.Anti-Trichomonas vaginalis activity from triterpenoid derivatives.Documentation of in vivo and in vitro aerobic resistance of feline Tritrichomonas foetus isolates to ronidazole.Paromomycin treatment of recalcitrant Trichomonas vaginalis.

P2860

Q24670198-AFAF18EA-BBA6-4B9E-84B7-B96755D8D19A Q27653958-F9BE50BB-B8C7-4B9F-83BB-F44EAA69BAE7 Q27673695-5038BF99-41A5-4C7F-8DD8-4D702B140F7B Q28480744-BFEC13CD-5B41-4E8E-AB02-1A339DE7A019 Q28750059-9972C1E6-FBDF-41C1-8EFF-B677E983B5CB Q30235029-F0C86EBB-98ED-4454-8EC1-41240A70D55E Q33214943-2E0AC2B3-6F7E-4F71-B113-083E4BDD427B Q33630457-D959426C-4049-4084-BE9A-C3FA8C400106 Q34173528-1BA81280-2114-4BF5-BDBC-9BD1CA8F8E5F Q34461645-4F258918-AAC9-4628-9703-2E714A9FB4B8 Q34587095-C821333D-86AC-4FEA-946F-A6DEF00A25E0 Q34601985-FA824F23-A505-4CC2-9C7A-01D949E375F1 Q35177948-AEA62FDC-F927-46E6-B12C-1C85EE0268C8 Q35191603-148FEBC2-C5DD-4BA8-B554-EF67CB962048 Q35711523-01945350-AB9B-4FC9-8791-BB861137EE5C Q35758074-4CA83185-2228-4876-B305-FFDB5737FBE3 Q35829594-6E87A300-7EE0-4C44-B265-B6676A23C993 Q36010780-7942AB9F-6397-4BCB-B4B8-1782F5D49595 Q36059717-5B3D184E-E7CB-4358-83DF-F5FA4F5C32E4 Q36311500-A75BC01B-87FA-44FB-93FB-E855FC3C58FA Q36809212-B41AA8F4-D1D0-462C-9A51-B4D4CD396C1A Q37026582-C3F4592F-C482-4A3D-9C65-599A339B5CB2 Q37270533-EEBBAC1D-39FD-44E6-83F7-5F989200FEDD Q37645366-C9052A1C-12C7-4DA8-B6F8-FE16BCD5040D Q37707263-5C45DDFD-6725-4573-A6A3-1E2D75D01D78 Q37721730-583A103A-2FA8-4FA1-980B-26C3A95870A1 Q37834095-12E95A29-4639-48EC-B722-986FEA993733 Q37834329-E187C7C7-17F8-495D-8F8E-ABE910D52C74 Q37855843-AAF5B0B4-4835-4E61-BA8D-23420E845718 Q38130911-674339BF-41F0-410D-AF25-70C748748DB2 Q38215138-DF0029DB-07AC-4A7C-B583-BFE75A42910D Q38266507-61B5A014-F21B-4B9C-A145-E68E2886B1FA Q40076426-239F88CF-2655-4D18-82E9-E7BB68A884F5 Q40439416-DEE7AC1D-613B-496C-B660-1DB3583E57D8 Q40992190-D689EB6E-468E-45C4-875F-F1D8FC5A546B Q41019447-0266FCD2-5B40-4D51-A649-D698EFF15910 Q41912333-68F776F9-AE3F-4092-8452-37192222B600 Q42215647-4ACC729E-DCCC-45DE-932F-D0BC6C38422C Q43056993-022C1448-87B8-40BC-87A9-4DFFEFE431F4 Q43136738-6D579285-582F-483A-A331-C3069E8CAD6D

P2860

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

http://www.wikidata.org/entity/Q24563038

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

name

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

@ast

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

@en

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

@nl

type

label

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

@ast

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

@en

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

@nl

prefLabel

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

@ast

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

@en

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

@nl

P1433

Q24563038-B6B273BD-003B-4DA6-AA04-EB7AD468D4BF

P1476

Q24563038-AFA418A0-1F86-4CCD-8316-76C5817103BB

P2093

Q24563038-001046E3-0B1A-492D-9FF7-25F2C25F9F9E

Q24563038-947671DD-AF90-4581-BAB6-638DBB8FF611

Q24563038-ACD5AF29-DC56-4877-A726-886ADCD83258

Q24563038-C9648EB4-FE0E-4F70-BC05-D7E92E4985B1

Q24563038-EF2CFD7E-B888-4FB8-9511-6F2B7F6932FD

P2860

Q24563038-08040DE5-79E7-4756-B7F7-388907887250

Q24563038-0CC06820-8F12-4234-AA13-3B2ED4F2FF2A

Q24563038-127FD445-5B35-44D3-9CEC-58AC023B0B40

Q24563038-146DCDA7-7420-4C64-A0B5-5AF27A329D7F

Q24563038-1A7677B0-CFD1-4B61-978D-2B90BDB91E21

Q24563038-1DCA5E67-EF55-4FB1-A192-17599BC7C289

Q24563038-1DD6297C-48A7-481D-B081-E39D44804CA8

Q24563038-1EFAE780-704B-41DD-BF1E-0FB1DA2862BC

Q24563038-1FB5001C-3734-41E6-AA50-1706A86711C9

Q24563038-217570A9-3B65-43C7-9113-1E6E8AECF7D9

P304

Q24563038-E0EF01FF-AB43-4EE3-B2D3-BF690928ACD9

P31

Q24563038-B922D19D-7CE0-4347-A587-2030D5C34A43

P3181

Q24563038-CD680EF5-D848-4A1C-A4C8-747AF563661F

P356

Q24563038-65C6B923-657C-4586-B652-365A5A857F2B

P407

Q24563038-B8F69A58-4C31-4D5C-9D71-C68A6274160E

P433

Q24563038-B96E86E4-EDBE-4C4C-A1EB-F438BF33D63A

P478

Q24563038-193AF756-2268-4EEB-BD04-B1D31CA7CC3B

P577

Q24563038-ED830349-0EAB-46DE-A73B-B17707D2EFF7

P698

Q24563038-8BCB416E-A60F-4723-872D-33284675176C

P921

Q24563038-4814B739-0DF5-456A-B652-9F1B02A14574

P932

Q24563038-95151A5D-CE12-48D8-A969-28890EC762B2

P3181

P356

CMR.17.4.783-793.2004

P1433

Clinical Microbiology Reviews

P1476

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis

@en

P2093

Dino P Petrin

http://www.w3.org/2001/XMLSchema#string

Gary E Garber

http://www.w3.org/2001/XMLSchema#string

Kiera L Delgaty

http://www.w3.org/2001/XMLSchema#string

Sarah L Cudmore

http://www.w3.org/2001/XMLSchema#string

Shannon F Hayward-McClelland

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical and microbiological aspects of Trichomonas vaginalis

Drug targets and mechanisms of resistance in the anaerobic protozoa

Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus

Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action

Global prevalence and incidence estimates of selected curable STDs.

Immunotherapeutic effect of the lactobacillus vaccine, Solco Trichovac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis.

Evaluation of an enzyme-linked immunosorbent assay for the detection of antibody to Trichomonas vaginalis in sera and vaginal secretions.

Enzyme linked immunosorbent assay for detecting antibody to Trichomonas vaginalis: use of whole cells and aqueous extract as antigen.

Absorption and excretion of metronidazole. II. Studies on primary failures.

Further observations on strain sensitivity of Trichomonas vaginalis to metronidazole.

P304

783-93, table of contents

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5012304

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/CMR.17.4.783-793.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15489348

http://www.w3.org/2001/XMLSchema#string

P921

Trichomonas vaginalis

P932

523556

http://www.w3.org/2001/XMLSchema#string